Sorafenib versus Transarterial chemoembolization for advanced-stage hepatocellular carcinoma: a cost-effectiveness analysis
出版年份 2018 全文链接
标题
Sorafenib versus Transarterial chemoembolization for advanced-stage hepatocellular carcinoma: a cost-effectiveness analysis
作者
关键词
Sorafenib, Transarterial chemoembolization, Advanced-stage hepatocellular carcinoma, Cost-effectiveness analysis, Markov model
出版物
BMC CANCER
Volume 18, Issue 1, Pages -
出版商
Springer Nature
发表日期
2018-04-19
DOI
10.1186/s12885-018-4308-7
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Cost-effectiveness of Stereotactic Body Radiation Therapy versus Radiofrequency Ablation for Hepatocellular Carcinoma: A Markov Modeling Study
- (2017) Erqi L. Pollom et al. RADIOLOGY
- Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma
- (2016) Jordi Bruix et al. GASTROENTEROLOGY
- Prospective Study of Transcatheter Arterial Chemoembolization (TACE) with Ginsenoside Rg3 versus TACE Alone for the Treatment of Patients with Advanced Hepatocellular Carcinoma
- (2016) Bo Zhou et al. RADIOLOGY
- Cost-effectiveness of community-based screening and treatment for chronic hepatitis B in The Gambia: an economic modelling analysis
- (2016) Shevanthi Nayagam et al. Lancet Global Health
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cost-effectiveness of sorafenib as a first-line treatment for advanced hepatocellular carcinoma
- (2015) Pengfei Zhang et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Predictors of survival in patients with advanced hepatocellular carcinoma who permanently discontinued sorafenib
- (2015) Massimo Iavarone et al. HEPATOLOGY
- Comparison of Chemoembolization with and without Radiation Therapy and Sorafenib for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Propensity Score Analysis
- (2015) Gi-Ae Kim et al. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
- Determinants of Survival After Sorafenib Failure in Patients With BCLC-C Hepatocellular Carcinoma in Real-World Practice
- (2015) I-Cheng Lee et al. MEDICINE
- Prognosis of untreated hepatocellular carcinoma
- (2014) Edoardo G. Giannini et al. HEPATOLOGY
- Cost-effectiveness analysis of liver resection versus transplantation for early hepatocellular carcinoma within the Milan criteria
- (2014) Kheng Choon Lim et al. HEPATOLOGY
- Field practice study of half-dose sorafenib treatment on safety and efficacy for hepatocellular carcinoma: A propensity score analysis
- (2014) Manabu Morimoto et al. HEPATOLOGY RESEARCH
- Comparison of standard-dose and half-dose sorafenib therapy on clinical outcome in patients with unresectable hepatocellular carcinoma in field practice: A propensity score matching analysis
- (2014) HIROKI NISHIKAWA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Sorafenib Combined with Transarterial Chemoembolization versus Transarterial Chemoembolization Alone for Advanced-Stage Hepatocellular Carcinoma: A Propensity Score Matching Study
- (2014) Hao Hu et al. PLoS One
- Cost-effectiveness of sorafenib treatment in field practice for patients with hepatocellular carcinoma
- (2013) Calogero Cammà et al. HEPATOLOGY
- Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma
- (2013) Alessandro Cucchetti et al. JOURNAL OF HEPATOLOGY
- Transcatheter Arterial Chemoembolization for Advanced Hepatocellular Carcinoma with Portal Vein Invasion: Safety, Efficacy, and Prognostic Factors
- (2013) Ming-Chih Chern et al. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
- The feasibility of combined transcatheter arterial chemoembolization and radiotherapy for advanced hepatocellular carcinoma
- (2013) Ju-Yeon Cho et al. LIVER INTERNATIONAL
- Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to baseline status: Subset analyses of the phase III Sorafenib Asia–Pacific trial
- (2012) Ann-Lii Cheng et al. EUROPEAN JOURNAL OF CANCER
- Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
- (2012) Jordi Bruix et al. JOURNAL OF HEPATOLOGY
- The natural history of compensated HCV-related cirrhosis: A prospective long-term study
- (2012) Eduardo Vilar Gomez et al. JOURNAL OF HEPATOLOGY
- Hepatocellular carcinoma
- (2012) Alejandro Forner et al. LANCET
- Advanced-Stage Hepatocellular Carcinoma: Transarterial Chemoembolization versus Sorafenib
- (2012) Matthias Pinter et al. RADIOLOGY
- Comparison of the efficacy of transcatheter arterial chemoembolization and sorafenib for advanced hepatocellular carcinoma
- (2012) HIROKI NISHIKAWA et al. Experimental and Therapeutic Medicine
- Field-practice study of sorafenib therapy for hepatocellular carcinoma: A prospective multicenter study in Italy
- (2011) Massimo Iavarone et al. HEPATOLOGY
- Management of hepatocellular carcinoma: An update
- (2011) Jordi Bruix et al. HEPATOLOGY
- Survival of patients with advanced hepatocellular carcinoma: Sorafenib versus other treatments
- (2011) Hwi Young Kim et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Transarterial Chemoembolization Can Be Safely Performed in Patients with Hepatocellular Carcinoma Invading the Main Portal Vein and May Improve the Overall Survival
- (2011) Goh Eun Chung et al. RADIOLOGY
- Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Prospective Comparative Study
- (2010) Jun Luo et al. ANNALS OF SURGICAL ONCOLOGY
- Clinical outcome of 251 patients with extrahepatic metastasis at initial diagnosis of hepatocellular carcinoma: Does transarterial chemoembolization improve survival in these patients?
- (2010) Dong-Jun Yoo et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Economic evaluation of sorafenib in unresectable hepatocellular carcinoma
- (2010) Brian I. Carr et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
- (2010) Riccardo Lencioni et al. SEMINARS IN LIVER DISEASE
- Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion
- (2009) Kang Mo Kim et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- The Epidemiology of Newly Diagnosed Chronic Liver Disease in Gastroenterology Practices in the United States: Results From Population-Based Surveillance
- (2008) Beth P. Bell et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Economic evaluation of sorafenib in the treatment of hepatocellular carcinoma in Canada
- (2008) Noemi Muszbek et al. CURRENT MEDICAL RESEARCH AND OPINION
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold
- (2008) Scott D Grosse Expert Review of Pharmacoeconomics & Outcomes Research
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started